These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7318924)

  • 61. [Clinical effects of estramustine phosphate disodium (Estracyt) on prostatic cancer].
    Nishio S; Kishimoto T; Maekawa M; Kawakita J; Hayahara N; Yuki K; Morikawa Y; Yasumoto R; Kato Y; Funai K
    Hinyokika Kiyo; 1986 Nov; 32(11):1763-70. PubMed ID: 3825823
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Further studies on the influence of oestrogens on androgen dependent fructose formation in sex accessory organs.
    Thomas JA; Knych ET
    Acta Endocrinol (Copenh); 1966 Nov; 53(3):455-61. PubMed ID: 5953359
    [No Abstract]   [Full Text] [Related]  

  • 63. Relative affinities of estramustine phosphate metabolites to the cytosol oestrogen receptor of rat testis.
    Daehlin L; Södergård R; Damber JE
    Scand J Clin Lab Invest; 1986 Apr; 46(2):159-62. PubMed ID: 3715367
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Comparative study of cyproterone acetate and estramustine phosphate on the plasma levels of testosterone and gonadotrophic hormones in adenocarcinoma of the prostate].
    Alfonso Sánchez M; Pérez Herrero F; Urrutia Avisrror M; Vega Wong J; Lago Montero A
    Actas Urol Esp; 1986; 10(2):111-6. PubMed ID: 2942009
    [No Abstract]   [Full Text] [Related]  

  • 65. The absorption metabolism, and excretion of Estracyt (NSC 89199) in patients with prostatic cancer.
    Forshell GP; Müntzing J; Ek A; Lindstedt E; Dencker H
    Invest Urol; 1976 Sep; 14(2):128-31. PubMed ID: 972005
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Studies on the estramustine-binding protein in rat ventral prostate and in human prostate.
    Gustafsson JA; Björk P; Carlström K; Forsgren B; Hökfelt T; Pousette A; Högberg B
    Scand J Urol Nephrol Suppl; 1980; 55():133-4. PubMed ID: 6163205
    [No Abstract]   [Full Text] [Related]  

  • 67. [Drug information. Estramustini phophas (Estracyt)].
    Helsingborg/Lundbeck L
    Ugeskr Laeger; 1975 Sep; 137(38):2203-4. PubMed ID: 1166562
    [No Abstract]   [Full Text] [Related]  

  • 68. Androgen antagonistic effect of estramustine phosphate (EMP) metabolites on wild-type and mutated androgen receptor.
    Wang LG; Liu XM; Kreis W; Budman DR
    Biochem Pharmacol; 1998 May; 55(9):1427-33. PubMed ID: 10076535
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Influence of diethylstilbestrol, Leuprolelin (a luteinizing hormone-releasing hormone analog), Finasteride (a 5 alpha-reductase inhibitor), and castration on the lobar subdivisions of the rat prostate.
    Yamashita A; Hayashi N; Sugimura Y; Cunha GR; Kawamura J
    Prostate; 1996 Jul; 29(1):1-14. PubMed ID: 8685049
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Binding of estramustine, a nitrogen mustard derivative of estradiol-17 beta, in cytosol from rat ventral prostate.
    Forsgren B; Högberg B; Gustafsson JA; Pousette A
    Acta Pharm Suec; 1978; 15(1):23-32. PubMed ID: 645366
    [No Abstract]   [Full Text] [Related]  

  • 71. Uptake, metabolism and antiproliferative effect of estramustine phosphate in human glioma cell lines.
    von Schoultz E; Gunnarsson PO; Henriksson R
    Anticancer Res; 1989; 9(6):1713-6. PubMed ID: 2697186
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Growth and cell survival following treatment with estramustine nor-nitrogen mustard, estradiol and testosterone of a human prostatic cancer cell line (DU 145).
    Hartley-Asp B; Gunnarsson PO
    J Urol; 1982 Apr; 127(4):818-22. PubMed ID: 7069864
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of hormone-cytostatic complexes on the rat ventral prostate in vivo and in vitro.
    Forsberg JG; Hoisaeter PA
    Vitam Horm; 1975; 33():137-54. PubMed ID: 180672
    [No Abstract]   [Full Text] [Related]  

  • 74. Cytotoxicity of estramustine, a steroid-nitrogen mustard derivative, through non-DNA targets.
    Tew KD; Erickson LC; White G; Wang AL; Schein PS; Hartley-Asp B
    Mol Pharmacol; 1983 Sep; 24(2):324-8. PubMed ID: 6888373
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Uptake and metabolism in vivo of testosterone-1,2-3H by accessory sex organs of male rats; influence of some hormonal compounds.
    Tveter KJ; Aakvaag A
    Endocrinology; 1969 Oct; 85(4):683-9. PubMed ID: 4240878
    [No Abstract]   [Full Text] [Related]  

  • 76. Estramustine phosphate versus stilbestrol as primary treatment for metastatic cancer of the prostate.
    Nickel CJ; Morales A
    Can J Surg; 1983 Sep; 26(5):434-8. PubMed ID: 6351988
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Estramustine--current status, 1983.
    Ahlgren JD
    Semin Oncol; 1983 Sep; 10(3 Suppl 3):46-7. PubMed ID: 6364367
    [No Abstract]   [Full Text] [Related]  

  • 78. Estramustine: historical background and preclinical trials.
    Schein PS
    Semin Oncol; 1983 Sep; 10(3 Suppl 3):1-2. PubMed ID: 6686721
    [No Abstract]   [Full Text] [Related]  

  • 79. A randomized double blind crossover trial of diethylstilbestrol (DES) and estramustine phosphate (Emcyt) for stage D prostatic carcinoma.
    Benson RC; Gill GM; Cummings KB
    Semin Oncol; 1983 Sep; 10(3 Suppl 3):43-5. PubMed ID: 6364366
    [No Abstract]   [Full Text] [Related]  

  • 80. [Treatment of advanced carcinoma of the prostate with estramustine phosphate (estracyt)].
    Lancina Martín JA; Chantada Abal V; Lamas Meilan AC; González Martín M
    Actas Urol Esp; 1984; 8(5):399-402. PubMed ID: 6524487
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.